Altered signal transduction in cardiac ventricle overexpressing A(1)-adenosine receptors

Cardiovasc Res. 2003 Dec 1;60(3):529-37. doi: 10.1016/j.cardiores.2003.09.012.

Abstract

Objective: The aim of the present study was to assess the effects of A(1)-adenosine receptor (A1-AR) stimulation in ventricle of A(1)-adenosine receptor overexpressing mice (transgenic mice, TG).

Methods: Effects of the A(1)-adenosine receptor agonist R-PIA ((-)-N(6)-phenylisopropyladenosine) on phosphorylation of phospholamban (PLB), Ca(2+) transients, Ca(2+) currents and cell shortening were studied in isolated ventricular cardiomyocytes.

Results: R-PIA alone did not affect contractility in isolated electrically stimulated cardiomyocytes from wild-type mice (WT) or TG. However, after pre-stimulation of beta-adrenoceptors by isoproterenol, R-PIA reduced contractility in cardiomyocytes from WT but increased contractility in TG. Under the same conditions, R-PIA reduced isoproterenol-stimulated currents through L-type Ca(2+) channels, Ca(2+) transients and phosphorylation of PLB in cardiomyocytes from WT. In contrast, R-PIA diminished phospholamban phosphorylation induced by isoproterenol but augmented isoproterenol-elevated currents through L-type Ca(2+) channels, and isoproterenol-heightened Ca(2+) transients in cardiomyocytes from TG.

Conclusions: We suggest that A(1)-adenosine receptor overexpression reverses the interaction of beta-adrenergic and A(1)-adenosine receptor stimulation, at least in part. Hence, the receptor/effector coupling is dependent on receptor density in this model.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Animals
  • Calcium / metabolism
  • Calcium Channels / metabolism
  • Calcium-Binding Proteins / metabolism
  • Cardiotonic Agents / pharmacology
  • Cell Size / drug effects
  • Heart Ventricles
  • Isoproterenol / pharmacology
  • Mice
  • Mice, Transgenic
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Phosphorylation
  • Rats
  • Receptors, Purinergic P1 / genetics*
  • Signal Transduction*
  • Stimulation, Chemical

Substances

  • Calcium Channels
  • Calcium-Binding Proteins
  • Cardiotonic Agents
  • Receptors, Purinergic P1
  • phospholamban
  • N-(1-methyl-2-phenylethyl)adenosine
  • Adenosine
  • Isoproterenol
  • Calcium